Options Medical Weight Loss review
Priced, states unstated
A weight-loss brand that turns out to run a real longevity line — with NAD⁺ priced at a single published monthly figure.
Our verdict
The obvious assumption about Options Medical Weight Loss is that the name tells you everything, and it does not. It runs a separate Longevity category with its own program page, its own intake and a dedicated NAD⁺ treatment page carrying a flat $199 per month, with glutathione beside it. For a reader who wants one number rather than a tier ladder, that is useful and rare. The gap is geography: it publishes no list of states its telehealth arm covers, so you cannot confirm you are eligible before starting.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- NAD⁺ telehealth
- Access
- NAD⁺ injectable therapy $199 per month, HSA/FSA eligible; telehealth state coverage not published
- Insurance
- Cash-pay, no insurance
- Visit
- Async intake
- Availability
- Not published; confirmed at intake
- LegitScript
- Certified
- Updated
- July 2026
Popular alternative
Enhance MD
Physician-supervised NAD⁺ under lab-guided oversight
Check Enhance MD availability →What it is
Options Medical Weight Loss is an established medical weight-loss brand operating both physical clinics and a telehealth program. Its site is organised by category rather than by drug: Weight Loss (compounded semaglutide and tirzepatide, oral versions of both, phentermine, B12 and lipotropic injections), Hormones (a TRT program and an HRT program, with estradiol, progesterone and testosterone listed as treatments), and Longevity (a Longevity Program with NAD⁺ and glutathione as its named treatments). It is LegitScript certified and cash-pay with HSA/FSA eligibility stated.
How it works
Asynchronous intake into a structured program rather than a medication-only transaction, and the brand is explicit about that framing — it describes GLP-1 medication as one tool inside a broader metabolic-health plan with provider support and accountability. On the longevity side, the program page states that a treatment plan is personalised after a comprehensive medical assessment, which is the right framing for an injectable. Two structural things to weigh. First, this is a hybrid business with real physical clinics, which usually means a deeper clinical bench than a pure storefront, but the site does not name individual clinicians or a medical director on its telehealth pages. Second, and more practically, it publishes no state list for telehealth anywhere we could find, and its own FAQ language points you to intake to confirm coverage. That is a meaningful friction point for a reader deciding whether to hand over health history. LegitScript certification is displayed with a badge that links to the public checker, which is a real check on the pharmacy-and-advertising side but says nothing about who owns or staffs the business.
Pricing transparency
The NAD⁺ figure is clean and singular: $199 per month, stated on its own NAD⁺ injectable therapy page with a direct purchase button, not quoted after an intake. That is what we publish, and nothing else on the site should be read as an NAD⁺ price. For context on the rest of the menu — and only as context — telehealth weight-loss programs start at $199 a month with medication included if prescribed, semaglutide injections are advertised from $239, tirzepatide injections from $299, oral tirzepatide from $339 and higher tiers reach $399. HSA/FSA is accepted and flexible payment options are offered. What the NAD⁺ page does not state is the dose, the vial size or the injection frequency behind the $199, so ask what a month actually contains before comparing it against a competitor's monthly figure. Also ask whether the $199 includes the medical assessment the longevity program describes, or whether that is billed separately.
Branded vs compounded
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The brand does not name its compounding pharmacy, and compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, the longevity line is exactly the part of this market where the marketing runs furthest ahead of the data. Injected NAD⁺ has no controlled human outcome trials — the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly — while the NAD⁺ forms with human trial data are the oral precursors nicotinamide riboside and nicotinamide mononucleotide, and what those trials reliably demonstrate is a raised blood NAD⁺ level rather than a clinical benefit. Injectable glutathione has essentially no controlled human outcome data behind the claims attached to it. The compounded GLP-1s on the weight-loss side sit on a different footing: the underlying molecules have large randomised trials, but a compounded preparation of them is not the trialled product. Individual results vary.
Pros and watch-outs
What we like
- NAD⁺ injectable therapy carries a single published price of $199 per month on its own treatment page
- A genuine Longevity program with its own intake, not an afterthought tacked onto weight loss
- LegitScript certified with a badge that links to the public verification checker
- Hybrid model with real physical clinics behind the telehealth arm
- HSA/FSA eligible with flexible payment options stated
Watch-outs
- No state list published for the telehealth program — eligibility is only confirmed at intake
- Dose, vial size and injection frequency behind the $199 are not stated
- No individual clinician or medical director named on the telehealth pages
- Compounding pharmacy not named
- Program structure adds cost relative to a medication-only seller, by the brand's own framing
Best for
People who want NAD⁺ at one published monthly price inside an established clinical brand rather than a newly launched storefront.
Who should look elsewhere
Anyone who needs to confirm state eligibility before starting an intake, or who wants the dose stated before paying.
The evidence behind what Options Medical Weight Loss prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- NAD injections: how to get them near you or online, and what the evidence really says
Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.
- Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
How Options Medical Weight Loss compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Precision Telemed
NAD⁺ from a platform whose prescribers and pharmacies you can independently verify
See Precision Telemed → - PreventiveMD
NAD⁺ at a published all-in price from a platform that tells you up front whether it can treat you
See PreventiveMD → - PlexusDx
NAD⁺ at a published all-in monthly price with check-ins and no membership on top
See PlexusDx →
Peptides & longevity · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of Options Medical Weight Loss’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Does Options Medical Weight Loss actually sell anything other than GLP-1s?
- Yes. It runs a Longevity category with its own program page and two named treatments — NAD⁺ and glutathione — alongside separate TRT and HRT programs. The NAD⁺ injectable therapy page carries its own price and purchase button.
- What does NAD⁺ cost here?
- $199 per month, stated on the NAD⁺ injectable therapy page. Confirm what that month contains — dose, vial size and injection frequency are not published — and whether the comprehensive medical assessment the longevity program describes is included or billed separately.
- Which states does the telehealth program cover?
- It does not say. No state list is published for the telehealth arm, so eligibility is confirmed during intake. That is a real friction point, since you complete a health questionnaire before finding out.
- Is injected NAD⁺ supported by evidence?
- Not by controlled human outcome trials — there are none for the injected route. The NAD⁺ forms with human trial data are the oral precursors NR and NMN, and what those trials show is a raised blood NAD⁺ level, which is a biomarker rather than a demonstrated clinical benefit. Compounded medications are not FDA-approved.